Latest Advisory

  • Joint FDA-HFSRB Advisory No. 2015-001 || Accredited Health Facilities for Human Stem Cell and Cell-Based or Cellular Therapies and Approved Indications

    Joint FDA-HFSRB Advisory No. 2015-001 || Accredited Health Facilities for Human Stem Cell and Cell-Based or Cellular Therapies and Approved Indications

    Read more

  •  FDA Advisory No. 2015-063 || RECTIFICATION TO FDA ADVISORY NO. 2015-044 “RECALL OF SPECIFIC DRUG PRODUCTS OF MORISHITA-SEGGS PHARMACEUTICALS, INC. MANUFACTURED FROM JANUARY 2014 UP TO THE PRESENT”

    FDA Advisory No. 2015-063 || RECTIFICATION TO FDA ADVISORY NO. 2015-044 “RECALL OF SPECIFIC DRUG PRODUCTS OF MORISHITA-SEGGS PHARMACEUTICALS, INC. MANUFACTURED FROM JANUARY 2014 UP TO THE PRESENT”

    Read more

  •  FDA Advisory No. 2015-062 || PUBLIC WARNING AGAINST UNREGISTERED FOOD SUPPLEMENTS THAT ARE OFFERED FOR SALE IN THE MARKET AND THRU THE INTERNET

    FDA Advisory No. 2015-062 || PUBLIC WARNING AGAINST UNREGISTERED FOOD SUPPLEMENTS THAT ARE OFFERED FOR SALE IN THE MARKET AND THRU THE INTERNET

    Read more

  • FDA Advisory No. 2015-061 || TERMINATION OF PRODUCT RECALL ORDER ISSUED ON SPECIFIC BATCHES OF TETRAHYDROZOLINE HCl (EYE-MO RED EYES FORMULA) 0.05% OPHTHALMIC SOLUTION (EYE DROPS)

    FDA Advisory No. 2015-061 || TERMINATION OF PRODUCT RECALL ORDER ISSUED ON SPECIFIC BATCHES OF TETRAHYDROZOLINE HCl (EYE-MO RED EYES FORMULA) 0.05% OPHTHALMIC SOLUTION (EYE DROPS)

    Read more

  • FDA Advisory No. 2015-060 || TERMINATION OF PRODUCT RECALL ORDER ISSUED ON SPECIFIC LOT JKN0969B OF DOXORUBICIN HYDROCHLORIDE 2 mg/mL (20 mg/10 mL) PEGYLATED LIPOSOMAL CONCENTRATE FOR I.V. INFUSION (CASPRIA)

    FDA Advisory No. 2015-060 || TERMINATION OF PRODUCT RECALL ORDER ISSUED ON SPECIFIC LOT JKN0969B OF DOXORUBICIN HYDROCHLORIDE 2 mg/mL (20 mg/10 mL) PEGYLATED LIPOSOMAL CONCENTRATE FOR I.V. INFUSION (CASPRIA)

    Read more

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter